BMN 111-301: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN 111 in Children with Achondroplasia

Project: Research project

Project Details

StatusActive
Effective start/end date10/1/178/31/50

Funding

  • BioMarin Pharmaceutical Inc.